Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
Recruiting now · Phase 3
Conditions studied: Polysubstance Abuse, Opioid Use, Tobacco Use
In brief
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Key facts
- Study ID
- NCT06033599
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 420
- Starts
- 2023-09-05
- Expected to finish
- 2028-08-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- English-speaking
- Age ≥18
- Currently on methadone; and 4) currently smoke cigarettes.
You may not qualify if…
- Severe cognitive impairment (score >23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
- Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
- Inability to attend or fully participate in intervention sessions or assessments
- Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
- Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
- Any contraindications for NRT
- Currently or soon planning to be pregnant or breastfeeding.
Where it is running
- Rutgers Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States (enrolling)
- University of Utah — Salt Lake City, Utah, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.